Navigation Links
Senior Researcher With Extensive Healthcare Experience Joins Knowledge Networks
Date:5/7/2008

MENLO PARK, Calif., May 7 /PRNewswire/ -- As part of its ongoing commitment to providing the best research talent to its clients, Knowledge Networks (KN) is excited to welcome Katherine Anne Binns as Senior Vice President, Client Service, based in the company's New York office. KN will draw particularly on her exceptional experience in strategic research for the company's rapidly growing list of clients.

"Katherine possesses the expertise and mindset to recognize, describe, and, where necessary, challenge a client's core business issues, a capability that all our clients have come to expect from us," said Simon Kooyman, CEO of Knowledge Networks. "She is an accomplished leader with a consultative approach, and she is focused on both quality of data and translation of insights into real-world actions -- two areas in which KN excels. I am thrilled to see her join the dynamic team of senior research talent that Audrey Rosen and Justin Edge have built around them."

In her new position, Binns will focus on giving clients a deeper understanding of the consumer from a variety of perspectives, including connections among brands, media, and consumer attitudes and actions. Her work will include:
-- strategic solutions in the development of new product and service

offerings

-- deepening client understanding of their most important and profitable

target consumers and customers

-- helping companies anticipate and profit from emerging consumer and

societal trends

Before joining Knowledge Networks, Binns was Division President of Harris Interactive's Healthcare Practice. As leader of the Harris Interactive/Wall Street Journal Healthcare Poll, Binns also was a frequent speaker at industry conferences. Earlier at Harris Interactive, Binns was responsible for public policy and education research.

Binns received an M.B.A. from Leonard N. Stern School of Business at New York University, and she holds a
'/>"/>

SOURCE Knowledge Networks
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Oral Health a Matter of Life and Death for Seniors
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
4. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
5. Seniors Need a Safety Plan in Face of Disasters
6. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
7. High Co-Pays Cause Seniors to Go Without Meds
8. Governor Rendell Proclaims Sept. 9-15 as Senior Community Center Week
9. Poor Senior Vision Often a Window on Disease
10. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
11. Pharmacopeia Announces Senior Additions to Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...orporation Executive, Robert J. Reilly, Joins Aeth...on Inc.,( http://www.aethon.com ), the leading dev...n logistics, today announced that Robert J. Reilly...- Chief Financial Officer., Reilly, who was most ...esson Corporation,s Specialty Pharmacy Division, b...
(Date:7/25/2008)...25 /PRNewswire/ -- The Elekta Family of Companies ...t solutions at the 2008,American Association of Ph...trating how the joint forces of Elekta, IMPAC and ...planning and delivery solutions that,streamline th...for,patients, as well as enhance clinician efficie...
(Date:7/25/2008)...f., July 25 /PRNewswire/ -- AutoGenomics, Inc. tod...ement on Form S-1 with the,Securities and Exchange...c,offering of shares of its common stock. The numb... which are expected to be offered by,AutoGenomics,...not yet been,determined., J.P. Morgan Securities ...
(Date:7/25/2008)...ughest for those trying to drop pounds, study find...- Anyone who has avoided Monday morning weigh-ins ...ieter,s friend. , Now, researchers have some sc...s being their undoing: Most people do eat more on ...ht. , "Weekend indulgences can wreak havoc on w...
Breaking Medicine News(10 mins):Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
...r and death from cancer among Chinese women is ris...ai// Disease Prevention and Control Centre Friday....ghai urban area has almost doubled in 20 years and...ontracting the disease, the center reports. The l...
...rm Biocon Ltd Thursday announced the launch of ren...and reducing// the risk of such disease. As the l...ontinent, the company has set up a nephrology divi...odapt (Mycophenolate Mofeti), Tacrograf (Tacrolimu...
...a world-renowned California-based biomedical facil...ome up with a chemical// that would help prevent r...synthetic compound, called MTIP, blocks the action...-Releasing Factor (CRF), according to a joint anim...
...the food chain via the Bernard Matthews plant, whi...ird flu in early February this year. The Public ...ost 850 tons of turkey had to pass through the pla... had occurred in the interim period between outbre...
Other Medicine News:Health News:Biocon Unveils Renal Therapies for Kidney Disorders 2
(Date:7/24/2008)...re/ -- There are a record 301,new medicines being ...,report released here today during a briefing that...lnesses have on patients, their families,and soci...million American,adults. The briefing, led by the ...ca (PhRMA), featured Emmy Award-winning actor Joey...
(Date:7/24/2008)...-- MacroChem Corporation (OTC,Bulletin Board: MACM...ial,involving 37 patients who completed a 48-week,... study of EcoNail, a topical antifungal,lacquer fo...e composite,primary efficacy endpoint of the trial...(negative fungal culture and negative KOH) and cle...
(Date:7/23/2008)...armaceuticals (SPI) has filed,an Investigational N...testing of a proprietary formulation of ebselen fo...oss or ototoxicity. The oral capsule,containing eb...lung cancer,and head and neck cancer patients rece...second development program for SPI to enter clinic...
(Date:7/23/2008)...Code BioPharmaceutics, Inc.,an emerging biopharma...,results demonstrating the utility of their lead d...chronic blood disorder paroxysmal nocturnal,hemogl...nted at the XXII,International Complement Workshop...only treatment currently available for PNH patient...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2MIT works toward novel therapeutic device 4265 1MIT works toward novel therapeutic device 4265 2MIT works toward novel therapeutic device 4265 3Endobronchial valve significantly improves emphysema 912 1Endobronchial valve significantly improves emphysema 912 2Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 1Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 2Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 3New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 1New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 2
...NESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasd...,the scalable production, survival following engra...infarcted rats was presented,today for GRNCM1, the...therapeutic for heart failure, at the Internationa...eting in Cairns,Australia., The presentation was ...
...SS WIRE)--Jun 19, 2007 - Javelin,Pharmaceuticals (...ate Rylomine(TM) (intranasal morphine) successfull...e Pain Intensity Difference,(SPID) scores over 0-2...tal Phase 3 studies, patients with moderate-to-sev...ven 7.5 mg Rylomine every,hour as needed, 15 mg Ry...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 2Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 3Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 4
Blunt Tapered Tip in stainless steel.
...ipurpose gamma camera is designed for SPECT and PE...mbines the high-energy and PET imaging capability ...ECT and planar imaging, all in one unit.,The ...nd general nuclear medicine applications well beyo...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM
AXIOM Artis FA is a universal floor-mounted angiographic C-arm system whose flexible system architecture is ideal for vascular and non-vascular diagnostics and interventions. It provides complete erg
Medicine Products: